Cargando…
The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis
BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare, low-grade multisystem neoplastic disease. Most LAM patients are at a high risk of losing lung function at an accelerated rate and developing progressive dyspnea. Recently, several studies have reported their experience with pharmacological treatm...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023761/ https://www.ncbi.nlm.nih.gov/pubmed/32059669 http://dx.doi.org/10.1186/s12931-020-1316-3 |